Removing intellectual property protections on Covid-19 vaccines would substantially improve availability of the vaccines in developing countries.
Removing intellectual property protections on Covid-19 vaccines would have a negative impact on vaccine development efforts for future variants of SARS-CoV-2 or for the next pandemic.
Without an international agreement that facilitates vaccine trade, countries’ incentives to limit exports of vaccines and/or key production inputs are likely to prolong the adverse effects of the pandemic in advanced countries.
Allowing short selling of financial securities, such as stocks and government bonds, leads to prices that, on average, are closer to their fundamental values.
Requiring investors to disclose short positions in a stock at the equivalent threshold as they are required to do for long positions would result in significantly less short selling.
Regulatory restrictions on short selling - such as no naked shorts, temporary bans in times of crisis - make it difficult for optimists and pessimists to have equal influence on asset prices.
With Congress working on a $1.9 trillion Covid-19 relief package, potentially including an additional $1,400 in direct payments to individuals, we invited our US panel to express their views on the proposals. We asked the experts whether they agree or disagree with the following statements, and, if so, how strongly and with what degree of confidence:
